Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001628280-21-023781
Filing Date
2021-11-18
Accepted
2021-11-18 10:52:28
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 a111821crdf424b5.htm 424B5 473975
2 cardiff_logoxrgbxtma.jpg GRAPHIC 176318
  Complete submission text file 0001628280-21-023781.txt   703523
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Filer) CIK: 0001213037 (see all company filings)

EIN.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-254217 | Film No.: 211422969
SIC: 2836 Biological Products, (No Diagnostic Substances)